Chronic deep brain stimulation of the medial forebrain bundle reverses depressive-like behavior in a hemiparkinsonian rodent model by unknown
1 3
Exp Brain Res (2015) 233:3073–3085
DOI 10.1007/s00221-015-4375-9
RESEARCH ARTICLE
Chronic deep brain stimulation of the medial forebrain bundle 
reverses depressive‑like behavior in a hemiparkinsonian rodent 
model
Luciano L. Furlanetti1 · Volker A. Coenen1 · Iñigo A. Aranda1 · Máté D. Döbrössy1 
Received: 8 April 2015 / Accepted: 1 July 2015 / Published online: 21 July 2015 
© The Author(s) 2015. This article is published with open access at Springerlink.com
suggest that unilateral dopamine depletion did not preclude 
MFB-DBS in reversing depressive-like and anhedonic-like 
behavior in the rodent. Further understanding of the impor-
tance of hemispheric dominance in neuropsychiatric disor-
ders is essential in order to optimize stimulation as a thera-
peutic strategy in these diseases.
Keywords Chronic mild stress · Deep brain stimulation · 
Depression · Medial forebrain bundle · Rat model
Introduction
Neuropsychiatric manifestations of Parkinson’s disease 
(PD) have been associated to as much, if not more, mor-
bidity as its classic motor features. A high prevalence of 
major depression in this population has been reported 
(Wolters and Baumann 2013). In spite of a range of medi-
cal and nonmedical therapies available for the treatment of 
neuropsychiatric disorders, some of these current options 
are insufficient and lead patients to suboptimal outcome 
(Holtzheimer et al. 2012; Aarsland et al. 2014). During the 
last decade, neuromodulation has emerged as a potential 
therapeutic option and several methods that have invasive 
and noninvasive techniques have been described (Krack 
et al. 2010; Holtzheimer et al. 2012). Neuromodulation via 
deep brain stimulation (DBS) has shown in recent trials 
proof of principal in reversing symptoms of drug-resistant 
neuropsychiatric disorders, such as obsessive–compulsive 
disorder (OCD), Tourette syndrome, addiction and major 
depression (MDD) (Krack et al. 2010). Although many 
hypotheses have been proposed concerning the mecha-
nisms and neurocircuitries involved, the lack of a consen-
sus on the underlying pathology is reflected in the variety 
of DBS targets proposed in different studies. Clinical trials 
Abstract Preclinical and clinical evidence suggests that 
depression might be associated with a dysfunction in the 
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and experimental works have most commonly investigated 
the nucleus accumbens (NAC), subcallosal cingulate gyrus 
(SCG) and ventral capsule/ventral striatum (VC/VS) as 
options. However, if on the one hand the indications in 
favor to a specific target overlap across the different dis-
orders and, on the other hand, the average success rate for 
any of them for DBS does not overcome 50–60 %, doubts 
emerge as to the correctness of the targeted structures. 
Recently, an open-label clinical trial in (nonparkinsonian) 
chronically depressed patients stimulated the superolateral 
branch of the medial forebrain bundle (sIMFB), a structure 
that projects and interacts with all the previously selected 
targets. Stimulation provided a prompt and long-lasting 
improvement of depressive symptoms (Schlaepfer et al. 
2013). Previous preclinical research of our group has shown 
that high-frequency electric stimulation (HFS) of the MFB 
leads to an increased expression of the early gene c-fos in 
all the same brain areas previously aimed as a single tar-
get, showing a simultaneous and immediate effect of MFB 
stimulation on several distant key points of the mesolimbic 
and mesocortical system (Furlanetti et al. 2015b; Döbrössy 
et al. 2015). These findings have been reproduced by other 
authors also showing MFB-DBS to widely increase neu-
ronal activity in cortical and subcortical structures involved 
in the underlying circuitry of depression (Bregman et al. 
2015), in contrast to activation limited to cortical or subcor-
tical areas when targeting, for instance, the medial prefron-
tal cortex or the NAC (Hamani et al. 2014). This reinforces 
the rationale for MFB-DBS in the treatment of MDD and 
confirms that, rather than stimulation of a single target, it 
might be understood as neuromodulation of multiple affer-
ent and efferent connections, inducing short- and long-term 
adaptations in local and distal neuronal activity in key areas 
implicated in the neurocircuitry of depression.
In order to better understand the pathology of depres-
sion and in an attempt to optimize medical treatment, ani-
mal models of depression have been applied in preclini-
cal research. One way of establishing these models is by 
inducing key symptoms of the disease that are manifested 
as depressive-like behavioral phenotype. For example, 
the continuous exposure to a sequence of mild stressors, 
such as small periods of food deprivation and cage tilting, 
leads rats to develop depressive-like behavior that can be 
evaluated according to the animal’s performance in spe-
cific behavior testings (Willner 2005). In our previous 
clinical research, we have speculated that slMFB DBS in 
MDD is effective because of a bilateral activation of the 
ventral tegmental area (VTA) via recruitment of gluta-
matergic descending fibers of the MFB that in turn might 
change DA-metabolism in the remote nodes of the net-
work (Schlaepfer et al. 2013, 2014). The aim of the cur-
rent experiment was to first evaluate the effects of chronic 
and continuous bilateral MFB-DBS on a validated rodent 
model of depression, and secondly to investigate if unilat-
eral depletion of dopamine in the nigrostriatal, mesocortico 
and mesolimbic pathways would preclude MFB neuromod-
ulation of rescuing rat’s normal phenotype.
Our results validate the CMS model and provide data, 
showing that stimulation of the MFB was effective in 
reversing despair- and anhedonic-like behavior, despite 




Young adult female Sprague-Dawley (SD) rats (n = 13, 
Charles River, Germany), weighing 250 g, were housed in 
individual round cages (height: 40 cm; diameter: 40 cm), 
with the light/dark cycle maintained at 12 h on and 12 h 
off with food and water available ad libitum. After 2 weeks 
of handling and habituation, rats (n = 13) received a uni-
lateral lesion via stereotactic injection of 6-hydroxydo-
pamine (6-OHDA) in the right medial forebrain bundle 
(MFB), leading to complete dopamine depletion in the ipsi-
lateral nigrostriatal and mesolimbic pathways. Following 
18 months, baseline behavior tests were performed. Sub-
jects that did not reach the inclusion criteria of more than 
5 net ipsilateral rotation/min after amphetamine administra-
tion and <30 % use of the contralateral paw on the cylinder 
test were excluded from the study. Based on their perfor-
mance, groups were matched and animals (n = 9) selected 
for chronic mild stress protocol or to compose the control 
group. After six consecutive weeks of CMS, groups were 
once again matched and animals fell into three groups, 
i.e., CMS-STIM (n = 5), CMS-noSTIM (n = 4) or control 
(n = 4). Before the final round of behavior tests, 1 week 
of continuous MFB-DBS (CMS-STIM group) or sham 
stimulation (CMS-noSTIM group) was performed. Then, 
animals were finally transcardially perfused, and brains 
prepared for histological assessment. The study described 
in this manuscript was approved by the local veterinary 
authorities (Regierungspraesidium; TVA G10-124) and was 
carried out in accordance with the EU Directive 2010/63/
EU concerning the protection of animals used for scientific 
purposes. Experimental groups and design are summarized 
in Fig. 1.
Chronic mild stress protocol
The animals (CMS-STIM, CMS-noSTIM groups) were 
exposed to a variety of mild stresses, such as disruption of 
light/dark cycle, cage tilting, isolation and paired housing, 
stroboscopic light, soiled cage, brief food/ water restriction 
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and white noise, for a maximum of 6 consecutive weeks. 
Monitoring of health status and animal’s welfare by weight 
measurements (twice a week) and sucrose preference test 
(SPT) in a weekly basis looking at changes in hedonic 
experiencing were addressed during this period (Willner 
et al. 1987; Forbes et al. 1996).
Surgical procedures
Rats underwent general anesthesia induced and maintained 
by inhalation of isoflurane 2 %. First, 6-OHDA (3.6 µg/
µl in 0.2 % ascorbic acid and 0.9 % saline; Sigma, USA) 
was unilaterally injected in two tracks in the MFB at the 
following coordinates relative to bregma: track 1, tooth 
bar (TB) set at = +3.4; anteroposterior (AP) = −4.0; lat-
eral (L) = −0.8; dorsoventral (DV) = −8.0; and track 2, 
TB = −2.3; AP = −4.4; L = −0.8; DV = −7.8. In total, 
each animal received 5.5 µl of solution at a rate of 1 µl/min. 
In a second time point, bipolar electrodes (125 µm diam-
eter each, 90 % platinum/10 % iridium, 15-mm-length 
Teflon-coated shaft, World Precision Instruments, Sara-
sota, USA) were stereotactically bilaterally implanted into 
the MFB and permanently fixed to the skull surface with 
microscrews and bone cement. Anterior–posterior (AP) 
and mediolateral (ML) coordinates are taken from bregma, 
and DV coordinate from dura. AP = −4.4, ML = ±1.2, 
DV = −7.8. A single-shot buprenorphine (75 μg/Kg, i.p.) 
was given to all animals for postoperative analgesia.
Deep brain stimulation
Following 2 weeks of postsurgical recovery, the groups were 
matched and animals connected to the pulse generator (STG 
2008, Multichannel Systems, Germany) for stimulation 
(square-wave biphasic constant current, 130 Hz, 100 μs and 
250 µA average amperage) or sham stimulation, as previously 
described elsewhere (Furlanetti et al. 2015a). The current was 
individually titrated for each cerebral hemisphere, beginning 
with 50 μA to a maximum of 350 μA. If unwanted behaviors 
were observed during the titration process, the current was set 
50 µA less than the level that provoked side effects (e.g., rota-
tional behavior, dystonic movements). Chronic and continu-
ous MFB-DBS was performed for 7 consecutive days. The 
CMS-noSTIM group had burr holes drilled on their heads, 
but electrodes were not implanted. A third group served as 
control for health status monitoring and behavior tests.
Behavioral assessment
Behavioral tests were performed at three different time 
points along the experiment, i.e., (1) baseline (following 
unilateral 6-OHDA injection); (2) post-CMS protocol; and 
(3) post-MFB-DBS.
Ultrasonic vocalization test (USV)
Rats emit distinct types of USVs, depending on age, environ-
mental factors and the subject’s current emotional state. Low-
frequency vocalizations (around 22 kHz) reflect a negative 
affective or aversive behavior, whilst ultrasonic vocalizations 
(USVs) in the high-frequency range (50 kHz) correlate with 
pleasurable or rewarding experiences (Knutson et al. 1998; 
Burgdorf et al. 2000; Burgdorf and Panksepp 2006; Wöhr 
et al. 2008; Sadananda et al. 2008). Testing was performed in 
individual Plexiglas cages with the recording microphones, 























Fig. 1  Experimental groups and study design. MFB medial forebrain bundle, 6-OHDA 6-hydroxydopamine, CMS chronic mild stress, DBS deep 
brain stimulation, BT behavior tests. Gray patterned areas indicate “sham” procedure
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the bottom and connected to an UltrasoundGate (Metris, Neth-
erlands) and finally to a computer. Usual environmental condi-
tions were maintained during the 2 h of continuous recording. 
Behavior analysis was performed using an automated evalu-
ation system (Sonotrack 2.0, Metris, Netherlands). The num-
ber of events that occurred in each frequency range during the 
experiment was acquired for statistical assessment.
Forced swim test (FST)
Forced swim test (FST) is typically used to assess the anti-
depressant effect of drugs or other treatments in rodents 
(Porsolt et al. 2001; Overstreet 2012; Slattery and Cryan 
2012). The protocol consists of placing the animal into a 
cylindrical receptacle (40 cm high, 20 cm diameter) filled 
with water (25 °C) and measuring the time of activity and 
immobility. The water level was adjusted so that the rat 
could not touch the bottom of the container with its tail and 
could not escape from the cylinder either. Behavior activity 
was recorded for 7 min by a digital video camera connected 
to the workstation (Viewer2, Biobserve, Germany). The 
amount of time spent in a posture of immobility was cal-
culated. In accordance with the literature, immobility was 
defined as: (1) no movement of the three out four paws, (2) 
no struggling, (3) floating behavior.
Sucrose preference test (SPT)
The SPT assess anhedonia-like behavior or better the 
hedonic response in rodents. It was performed at the same 
time points as the other tests, plus in a weekly basis dur-
ing the CMS protocol. Reduced preference for the sucrose 
solution indicates a decreased sensitivity to rewarding expe-
riences and is understood as a preclinical correlate of anhe-
donia (Willner et al. 1987; Willner 2005). During this test, 
rats were offered for 24 h 2 bottles containing 400 ml, one 
with 5 % sucrose solution and the other tap water. Prior to 
the test, animals were not deprived of food or water. The 
amount of consumed water and sucrose solution was then 
calculated and presented as a percentage of the total volume.
Drug-induced rotation
 Rats were placed in rotameter bowls connected to a com-
puter. A customized system was adapted from the original 
design of Ungerstedt (1971), allowing the test to be carried 
out under continuous DBS. Ipsilateral and contralateral 
rotations were recorded over 90 min after amphetamine 
injection (2.5 mg/kg i.p., Sigma; in 0.9 % saline). Data are 
presented as net ipsilateral or contralateral turns/min.
Cylinder test
Forelimb movement asymmetry and exploratory behavior 
were tested with the cylinder test (Schallert et al. 2000; 
Cordeiro et al. 2014) following MFB lesion (BL) and in the 
other sessions indicated above. The animals were placed in 
the center of a 20-cm-diameter clear Plexiglas cylinder, and 
their exploratory behavior was recorded with a camera for 
4 min. The number of times the animal made clear contact 
Fig. 2  Weight dynamics. During the CMS protocol, statistical sig-
nificance toward a mild loss of body weight in the CMS groups in 
comparison with the controls was observed (p < 0.01). MFB-DBS 
also led to a temporary decrease in weight in the CMS-STIM group; 
however a prompt recovery even during ongoing stimulation occurred 
(p = 0.01). Asterisks indicate statistical significance across groups
Fig. 3  Behavioral testing. a, b Ultrasonic vocalization (USV): the 
chronic mild stress protocol (CMS) led to an increase in the number 
of calls at 22 kHz (CMS-STIM vs control, p = 0.03, CMS-noSTIM 
vs control, p = 0.05) as well as to a decrement of high-frequency 
calls (CMS-STIM vs control, p = 0.001, CMS-noSTIM, p = 0.001). 
Following MFB-DBS, a session effect was detected, with an increase 
of 50 kHz calls in the CMS-STIM group (p = 0.005); c forced swim 
test (FST): Exposure to mild stressors caused exacerbation of despair 
(CMS-STIM vs control, p = 0.0004, CMS-noSTIM vs control, 
p = 0.0003) that was reverted by chronic stimulation of the MFB to 
a level comparable with the control group (CMS-STIM vs control, 
p = 0.3, CMS-noSTIM vs control, p = 0.02, CMS-STIM vs CMS-
noSTIM p = 0.003); d sucrose preference test (SPT): anhedonic-like 
behavior was induced by CMS (CMS-STIM vs control, p = 0.01, 
CMS-noSTIM vs control, p = 0.06, CMS-STIM vs CMS-noSTIM, 
p = 0.1) and rescued by MFB-DBS (CMS-STIM vs control, p = 0.8, 
CMS-noSTIM vs control, p = 0.02, CMS-STIM vs CMS-noSTIM, 
p = 0.03); e, f amphetamine-induced rotation and cylinder test: 
assessment of forelimb akinesia and drug-induced rotational behavior 
did not reveal any impact of neither the mild stressors nor the neuro-
modulation of the MFB on behavioral outcome (p = 0.6 and p = 0.1, 
respectively). BL baseline test, post-CMS behavior tests following the 
chronic mild stress protocol, post-MFB-HFS behavior assessment 
after chronic continuous high-frequency deep brain stimulation of 
the medial forebrain bundle. Asterisks indicate statistical significance 
across groups/sessions
▸
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with the cylinder wall, using either the ipsilateral or the 
contralateral forepaw, was counted, and the data expressed 
as the percentage of contralateral paw use with respect to 
the total touches made.
Immunohistochemistry and histological analysis
Following the final round of behavior tests, animals 
were terminally anesthetized by an overdose of 10 % 
ketamine (Bela-Pharm GmbH & Co. KG, Germany) and 
2 % xylazine (Rompun, Bayer-Leverkusen, Germany) 
and intracardially perfused with a solution contain-
ing 4 % paraformaldehyde and 0.025 % glutaraldehyde 
in 0.1 M phosphate buffer at pH 7.4. The brains were 
removed from the skull, kept in 30 % sucrose at 4 °C 
until they sunk, and cut into 40 μm coronal sections. The 
free-floating sections were incubated with 1.5 % H2O2, 
1 % sodium borohydride and 1 % milk powder, each in 
0.02 M sodium phosphate buffer at pH 7.4 for 30 min, 
and exposed to a primary antibody raised in goat against 
c-fos (SC-52-G, 1:2000, Santa Cruz Biotechnology Inc., 
Santa Cruz, USA), or mouse anti-tyrosine hydroxylase 
(TH) (1:2500; Sigma-Aldrich, Steinheim, Germany), or 
rabbit anti-serotonin (1:2000; Sigma S5545, Darmstadt, 
Germany). After incubation for 48 h at 4 °C, visualiza-
tion of antibody-binding sites was based on DAB stain-
ing using biotinylated anti-goat (BA-5000; 1:200; Vec-
tor Laboratories, Inc., Burlingame, USA) or biotinylated 
anti-mouse (BA-2001; 1:200; Vector Laboratories, Inc., 
Burlingame, USA) as secondary antibody and avidin-
biotin technique (ABC Elite; Vector Laboratories, Burl-
ingame, CA) for signal intensification. Finally 3,3′-diam-
inobenzidine (DAB; Merk, Darmstadt, Germany) and 
0.01 % H2O2 were used to develop the color reaction. 
The sections were mounted on super frost plus slides 
(Langenbrinck, Emmendingen, Germany), dehydrated in 
ascending alcohol solutions and cleared in xylene before 
they were coverslipped with Histofluid (Marienfeld 
Laborglas, Lauda-Königshofen, Germany).
Assessment of the final electrode position was carried 
out by overlapping the TH histological sections and the 
respective slice found on a standard stereotaxic rat brain 
atlas. C-fos (in the prelimbic frontal cortex, lateral habenu-
lar nucleus and shell of the accumbens) and 5-HT (in the 
dorsal raphe nucleus (DRN), prelimbic frontal cortex and 
accumbens) expressions were quantitatively assessed, 
using a Leica DMRB microscope and the Stereoinvesti-
gator software (MFB Bioscience, USA). Immunoreactiv-
ity was estimated using Abercrombie’s correction formula 
P = M/(D + M)A × N, where P = total immunoreactivity, 
M = section thickness (here, 40 µm), D = average diameter 
of the stained structures, A = number of counted units and 
N = number of cut series (6).
Statistics
Two- or three-way ANOVAs with repeated measures were 
used (Statistica, StatSoft, Inc., USA). In all cases, the main 
effects were tested for groups (CMS-STIM, CMS-noSTIM, 
control), and sessions (baseline, post-CMS, post-MFB-
DBS). When appropriate, post hoc analyses were performed 
using Student–Newman–Keuls test. Level of significance 
was set at p < 0.05. Results are expressed as mean ± stand-
ard error of the mean (SEM).
Results
The weight of the animals was regularly monitored dur-
ing the study. The CMS protocol did not have a signifi-
cant bearing on the animals’ weight dynamics, but a mild 
and temporary reduction was observed (5–10 % of the 
initial body mass), similar to following the first days of 
MFB stimulation [group × session, F (18,180) = 2.44, 
p = 0.001]. After a variable period, the animals continued 
to gain weight again normally (Fig. 2).
Behavioral assessment
Both motor and nonmotor behavioral aspects were assessed 
along the experiment. A baseline test session revealed in all 
groups a typical lateralized forelimb movement asymmetry 
due to unilateral dopamine depletion in the nigrostriatal and 
mesolimbic pathways, tested with amphetamine-induced 
rotation and cylinder tests. Neither improvement nor wors-
ening of the motor deficits was observed following CMS 
protocol or MFB-DBS [Fig. 3e (amph-induced rotation), 
group × session, F (2,10) = 0.52, p = 0.6; Fig. 3f (cylinder 
test), group × session, F (2,10) = 2.87, p = 0.1].
Anhedonic behavior was measured using the SPT. The 
data show that all tested animals presented a similar per-
centage of sucrose solution consumption prior to CMS. 
Along the CMS protocol, both CMS-STIM and CMS-
noSTIM groups showed a weekly decrement in sucrose 
preference with an overall 23 % drop by the end of CMS 
[Fig. 3d, group × session, F (4,20) = 2.98, p = 0.04]. This 
could be translated as installation of anhedonic-like behav-
ior induced by a sequence of mild stressors. Chronic con-
tinuous stimulation of the MFB led, on the other hand, to 
a significant increase in the amount of sucrose solution 
drunk, showing strong positive effect on rescuing a pheno-
type comparable to the controls (p = 0.02). Similarly, per-
formance on the FST, which evaluates behavioral despair, 
dropped 83 % in the groups submitted to the CMS proto-
col [Fig. 3c, group × session, F (4,20) = 9.18, p < 0.001], 
whilst 1 week of chronic and continuous MFB-DBS reduced 
immobility from 65.9 ± 11.2 to 6.1 ± 1.9 % (p = 0.0001).
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The impact of CMS and DBS of the mesolimbic cir-
cuitry on USV, specifically on appetitive 50 kHz and 
aversive 22 kHz USVs, was also tested. Following the 
period of CMS, a significant increase in the number of 
aversive calls [Fig. 3a, group × session, F (2,10) = 4.34, 
p = 0.04], accompanied by a drop of events in the 50-kHz 
range, was observed (p = 0.04). Interestingly, once 
again MFB-DBS showed a strong effect toward an inver-
sion of this profile, with 86 % reduction of 22 kHz calls, 
paralleled with an increase of 50 kHz USVs among the 
CMS-STIM [Fig. 3b, group × session, F (4,20) = 5.01, 
p = 0.005], while their nontreated counterparts (CMS-
noSTIM) did not present any improvement (p = 0.5). 
These findings reveal a persistent aversive phenotype 
induced by chronic stress that was reversed by DBS.
Histology
The consistency and accuracy of the bilateral electrode 
implantation were addressed and confirmed on the TH 
staining, showing the tip of the electrodes within the bor-
ders of the MFB at the level of the lateral hypothalamus 
(LH) (Fig. 4b). A severe depletion of TH-positive neurons 
and fibers on the right nigrostriatal, mesolimbic and meso-
cortical pathways was observed (Fig. 4a–c). Interestingly, 


















Fig. 4  Tyrosine hydroxylase (TH) and serotonin (5HT) immu-
nostainings. A complete unilateral dopamine depletion following the 
injection of 6-OHDA in the right medial forebrain bundle (MFB) is 
represented on micrographs (a–c). The asterisks indicate the tip of 
the stimulating electrodes placed bilaterally into the MBF (b). MFB-
DBS led to an increase in the number of 5HT immunoreactivity in the 
dorsal raphe nucleus (DRN) (d). Arrows indicate positive staining in 
the DRN. CPu caudate-putamen (striatum), aca anterior commissure, 
AcbSH nucleus accumbens, shell, AcbC nucleus accumbens core, 3V 
third ventricle, Aq aqueduct, Tu olfactory tubercle, PAG periaque-
ductal gray, VTA ventral tegmental area, SN substantia nigra, DRNv 
dorsal raphe nucleus, ventral part, DRNd dorsal raphe nucleus, dorsal 
part, Rf reticular formation
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expression in the prelimbic frontal cortex (PRL) induced 
by selective stimulation of the MFB (Figs. 5a, b, 6b, 
p = 0.01). However, unilateral depletion of dopaminergic 
fibers via injection of 6-OHDA in the right MFB reduced 
the effect of MFB-DBS on activating c-fos expression in 
the shell of the NAC (Figs. 5c, 6b, p = 0.08). Compared to 
controls, MFB neuromodulation also induced a statistically 
significant 3.5-fold increase in serotoninergic immunoreac-
tivity in the DRN (Fig. 6a, p < 0.001) and a strong, but not 
significant, increase in the PRL (p = 0.07).
Discussion
Electrical stimulation of the superolateral branch of the 
medial forebrain bundle has been shown to produce rapid 
and long-lasting anti-depressive effects in major depression 
patients resistant to the conventional therapies (Schlaepfer 
et al. 2013; Coenen et al. 2013). Acute electrical stimu-
lation targeting the MFB and associated pathways have 
been investigated in preclinical models of psychiatric dis-
orders (Corbett and Wise 1980; Carlezon and Chartoff 
2007; Sagara et al. 2010; Rea et al. 2014; Döbrössy et al. 
2015); however, there is no general consensual hypothesis 
concerning the mechanistic explanations for how neuro-
modulation of the MFB impacts on the network model of 
depression (Mayberg 1997; Döbrössy et al. 2015) although 
groups have speculated about this (Schlaepfer et al. 2014). 
In the current experiment, a combined hemiparkinsonian 
and chronic mild stress model of depression was used to 
evaluate the behavioral impact of bilateral chronic continu-
ous high-frequency stimulation of the MFB. Histological 
methods were employed to shed light on possible biologi-













Fig. 5   c-fos immunostaining following bilateral chronic continuous 
MFB-DBS. The micrographs show a strong expression of the early 
gene c-fos in the prelimbic frontal cortex (a–b), and mild upregula-
tion of this marker in the shell of the nucleus accumbens and lateral 
habenular nucleus (c, d, respectively). Arrows indicate positive stain-
ing. CPu caudate-putamen (striatum), PRL prelimbic frontal cortex, 
aca anterior commissure, AcbSH nucleus accumbens, shell, AcbC 
nucleus accumbens Core, 3V third ventricle; LHab lateral habenular 
nucleus, MHab medial habenular nucleus, PVP paraventricular tha-
lamic nucleus
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stimulation parameters of MFB-DBS induce recovery of 
anhedonic- and depressive-like behaviors in an established 
animal model of depression. Unilateral depletion of DA 
neurons did not preclude overall (and especially ipsilateral) 
neural activation and upregulation of c-fos expression in 
ascending target areas such as in the shell of the NAC and 
prelimbic frontal cortex (PRL), whilst MFB stimulation led 
to an increased expression of 5-HT both in the PRL and in 
the DRN, indicating that neurotransmitters other than dopa-
mine might be involved, additionally.
The chronic mild stress model of depression
Preclinical and experimental research using animal mod-
els of human diseases can shed light on the mechanisms 
of the diseases or help evaluate new treatment strategies. 
The etiology of depression is currently not understood 
but is considered to arise from the dysregulation of neu-
ronal activity in numerous loci on the limbic-cortical cir-
cuit (Mayberg 1997). Two core symptoms of depression 
in humans are anhedonia and reduced motivation, which 
in the animal models of depression are assessed by the 
sucrose preference (SPT) and the FST, respectively. Since 
its introduction in the late 1980s, and the development of 
theories that stress and traumatic life events can promote 
the manifestation of depression (Kessler 1997; de Kloet 
et al. 2005), the CMS model has shown to provide a unique 
combination of predictive, face and construct validities and 
therefore has been used in numerous preclinical studies 
(Forbes et al. 1996; Willner 2005; Hamani and Temel 2012; 
Döbrössy et al. 2015). In the present experiment, continu-
ous exposure of the animals to CMS procedures led to a 
weekly reduction in the preference for sucrose solution in 
the SPT, as well as to a significant increase in immobility 
in the FST, in comparison with the baseline tests and con-
trol animals (Willner et al. 1987; Papp et al. 1991; Mus-
cat et al. 1992; Sikiric et al. 2000; Bielajew et al. 2003). 
Along with classic behavioral tests, UVS paradigms have 
also been applied in preclinical research for assessment 
of animal’s affective state (Knutson et al. 1998; Burgdorf 
et al. 2000; Wöhr and Schwarting 2007; Portfors 2007). 
Studies have indicated that, in rats, 22 kHz calls are closely 
associated with aversive events and, for instance, can be 
elicited by fear conditioning (Wöhr et al. 2005), handling 
the animal for the first time (Brudzynski and Ociepa 1992) 
or following social isolation (Francis 1977). Conversely, 
high-frequency USVs usually translate a positive affec-
tive state (Wöhr et al. 2008). Rats emit 50 kHz calls during 
mating (while approaching and investigating the partner) 
and also in a nonsexual context, in order to (re-)establish 
or to maintain contact among conspecifics (Burgdorf et al. 
2000; Wöhr and Schwarting 2007). In line with this, in the 
present experiment, rats chronically exposed to stressors 
showed a decreased number of calls in the 50-kHz range 
and a higher number of aversive USV compared to the con-
trols. Activation of the SEEKING system via neuromodula-
tion of the MFB (Panksepp 1998; Coenen et al. 2011) likely 
led to 4.1-fold increase in the number of 50 kHz calls. This 
behavioral change was accompanied by increased seroton-
ergic immunoreactivity in the DRN, as well as by a higher 
Fig. 6   Stereological assessment of 5HT and c-fos expression fol-
lowing MFB-DBS. A significant increment of 5HT immunoreactiv-
ity in the DRN in the CMS-STIM group was observed (p < 0.001) 
(a). Although not statistically significant, MFB-DBS also led to a 
strong increase in 5HT immunolabeling in the prelimbic frontal 
cortex (PRL) (p = 0.07). Nevertheless, expression of the early gene 
c-fos in this same brain area was clearly upregulated (p = 0.01) 
and in the shell of the nucleus accumbens (NAC) also increased 
(p = 0.08) (b). No significant changes in c-fos activation in the lat-
eral habenular nucleus or 5HT expression in the NAC were observed 
(p = 0.3 and p = 0.9, respectively)
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expression of the early gene c-fos in the PRL. Although the 
mechanisms underlying this observation are not completely 
clear, electrical stimulation of the ventral medial prefrontal 
cortex—that sends projections to the DRN via the MFB—
has been shown to rescue animals from anti-depressive 
phenotype and induce increase in the size and density of 
serotonergic synapses (Veerakumar et al. 2014).
MFB‑DBS and the neurocircuitry of depression
The broad spectrum of different emotional, cognitive and 
autonomic symptoms observed in MDD patients appears 
to result from a dysfunction of the network rather than a 
defect of one specific region or imbalance of an particular 
pathway (Mayberg 1997; Panksepp 1998; Friedman et al. 
2009; Coenen et al. 2012; Anderson et al. 2012; Döbrössy 
et al. 2015). It is generally thought that the ventral striatal 
area is the major subcortical site where affective processes 
are integrated with action and motor behaviors. The mes-
olimbic/mesocortical ascending DA pathways—connect-
ing the VTA—to the NAC and the medial frontal cortex 
are considered as the neural substrate for the SEEKING 
system. It has been postulated that this system subserves 
reward-related, explorative behavior, including motivation 
and appetitive learning, and its dysfunction plays a key role 
in psychiatric disorders such as addiction, schizophrenia 
and depression (Panksepp 1998; Arnsten and Rubia 2012; 
Russo and Nestler 2013). Hyper-reactivity of this system in 
more complex settings could be present in addiction or cer-
tain forms of schizophrenia, whilst depression, anhedonia 
and lack of motivation are believed to be related to a hypo-
activity of this pathway. Although over the last decade neu-
romodulation of numerous brain regions associated with 
the neurocircuitry of depression has been attempted, the 
reported remission rate does not overcome 30–50 % (Jimé-
nez et al. 2005; Lozano et al. 2008; Malone et al. 2009; Sar-
torius et al. 2010; Kennedy et al. 2011; Puigdemont et al. 
2012; Bewernick et al. 2012). On the other hand, bilateral 
stimulation of the superolateral branch of the MFB showed 
antidepressant efficacy in patients within days and with 
relatively low intensities of stimulation (Schlaepfer et al. 
2013; Coenen et al. 2013). The reason for the near-imme-
diate effect is not yet known; however, likely, it is related 
to the pivotal role of the MFB in modulating/synchroniz-
ing the function of all the other key structures implicated 
in the network (Döbrössy et al. 2015). In the present study, 
MFB-DBS led to an increased expression of the early 
gene c-fos in the shell of the NAC, as well as of 5-HT in 
the dorsal part of the raphe nucleus, and of both markers 
in the PRL. The data suggest a role for both the activation 
of distant structures in this circuit and also the implication 
of neurotransmitters other than dopamine in the antidepres-
sant mechanisms of DBS in the treatment of depression 
(Hamani et al. 2010b, 2014). Therefore, neuromodulation 
of this system is considered as a potential therapeutic strat-
egy in the treatment of resistant MDD (Coenen et al. 2011; 
Schlaepfer et al. 2013; Döbrössy et al. 2015).
Potential mechanisms of action
Although experimental modeling of human mental illnesses 
in animals is crucial to better understand the neurobiologi-
cal mechanisms of diseases and their treatment options, one 
should be aware of its limitations (Matthews et al. 2005). 
The present study, aiming to investigate the role of midbrain 
dopaminergic projections in bilateral MFB-DBS-mediated 
phenotypical rescue in a model of depression, used a uni-
lateral lesion approach to disrupt dopamine availability 
in the NAC. Ideally, in order to address this issue, animals 
with bilateral 6-OHDA MFB lesions should have received 
bilateral MFB-DBS. However, it has been previously dem-
onstrated that adult rats survive poorly following complete 
bilateral MFB lesions due to aphagia, adipsia and severe 
motor impairments (Deumens et al. 2002). Differential 
effects of lateralized stimulation have been investigated by 
others, suggesting that targeting the left, but not the right, 
medial prefrontal cortex is associated with antidepressant-
like effect (Hamani et al. 2010a). On the other hand, lesion 
of the right, but not left, medial PFC was shown to lead to 
an anxiolytic effect with reduction in stress-induced corti-
costerone response via neuroendocrine and autonomic mod-
ulation (Sullivan and Gratton 1999, 2002).
Concrete evidence concerning the short- and long-
term biological consequences of DBS in animal models 
is scarce. Noninvasive, in vivo proton magnetic resonance 
spectroscopy imaging has shown to elevate both glutamate 
and GABA levels in the striatum in unilateral dopamine-
depleted hemiparkinsonian rats, and ipsilateral DBS of the 
subthalamic nucleus modified this state and normalized 
transmitter levels (Melon et al. 2015). Similarly, in the cur-
rent paper, we speculate that the MFB stimulation could 
have both direct and indirect impacts on the activity of ser-
otonergic and dopaminergic fibers.
Firstly, serotoninergic projections connecting the 
nucleus raphes dorsalis to the forebrain and to a number 
of areas of interest in the context of depression, such as 
mamillary body, lateral habenular nucleus, septum, hip-
pocampal and preoptic regions, NAC and amygdaloid com-
plex, travel through the MFB (Nieuwenhuys et al. 1982). 
MFB-DBS could modulate directly the activity of ascend-
ing serotonergic fibers in the MFB and increase transmis-
sion in the NAC and other target areas. In our experiments, 
we have observed that MFB-DBS has led to an upstream 
and downstream modulation of those fibers with conse-
quently overexpression of 5HT in key areas of the limbic 
network, namely the DRN and the medial PFC.
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However, MFB-DBS could also have secondary effect 
on dopaminergic transmission in the NAC: Recruitment of 
myelinated glutamatergic fibers that descend from the PFC 
and the striatum toward the VTA could increase tonic DA 
output (on the intact side) from the VTA to its ascending 
targets and lead to the reduction in the depressive pheno-
type. The upregulation of the early gene c-fos in the shell of 
the NAC and medial PFC seen in the study would confirm 
the increased activity in these distal targets following the 
stimulation.
In summary, although the actual mode of action of 
MFB-DBS remains unclear, evidences allow us to specu-
late toward the combined neuromodulation of multiple 
monoaminergic systems implicated in the network of 
depression. Whether unilateral modulation of the MFB 
with DBS would be sufficient for the management of TRD 
in humans remains to be investigated.
Conclusion
The benefits of DBS in the management of treatment-resist-
ant neuropsychiatric disorders have been presented over 
the last decade and remain under evaluation both in terms 
of effectiveness and safety. Not only the mechanisms of 
neuromodulation as an alternative treatment, but also the 
underlying neuropathology of the disease are under inves-
tigation and still need to be clarified. Neuromodulation 
in animal models of depression has been proven to be an 
important tool for addressing these issues. Recent clini-
cal work targeting the MFB by DBS in treatment-resistant 
depression confirmed this bundle as a promising target that 
deserves attention in preclinical studies. The current experi-
ment demonstrated that unilateral dopamine depletion does 
not preclude MFB-DBS in reversing depressive-like and 
anhedonic-like behavior. Upregulation of c-fos expression 
and increased 5-HT in key regions of the circuitry have been 
associated with behavioral improvement. Taken together, 
MFB-DBS should not be understood as an intervention on 
a simple target, but as neuromodulation of a whole circuitry, 
since neurotransmitters other than dopamine are addition-
ally involved. This confirms the strategic position of the 
MFB as its stimulation possibly recruits multiple afferent 
and efferent connections, inducing short- and long-term 
plastic adaptations in local and distal neuronal activity.
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